AI assistant
Sending…
Twist Bioscience Corp — Director's Dealing 2021
Nov 3, 2021
31873_dirs_2021-11-03_188dd9a7-9cac-4c70-a92f-9151b1a0ee17.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2021-11-01
Reporting Person: CHESS ROBERT (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-11-01 | Common Stock | S | 4000 | $120.1534 | Disposed | 51014 | Direct |
Footnotes
F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on February 12, 2021.
F2: Represents the weighted average sales price per share. The shares sold at prices ranging from $120.00 to $120.89 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
More from Twist Bioscience Corp
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 17
Interim / Quarterly Report
2026
Feb 26
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 25